Cargando…
Quantitative understanding of HepaRG cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics
An understanding of the quantitative relationship between bile canaliculus (BC) dynamics and the disruption of tight junctions (TJs) during drug‐induced intrahepatic cholestasis may lead to new strategies aimed at drug development and toxicity testing. To investigate the relationship between BC dyna...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137115/ https://www.ncbi.nlm.nih.gov/pubmed/35621230 http://dx.doi.org/10.1002/prp2.960 |
_version_ | 1784714309856657408 |
---|---|
author | Sonoi, Rie Hagihara, Yoshihisa |
author_facet | Sonoi, Rie Hagihara, Yoshihisa |
author_sort | Sonoi, Rie |
collection | PubMed |
description | An understanding of the quantitative relationship between bile canaliculus (BC) dynamics and the disruption of tight junctions (TJs) during drug‐induced intrahepatic cholestasis may lead to new strategies aimed at drug development and toxicity testing. To investigate the relationship between BC dynamics and TJ disruption, we retrospectively analyzed the extent of TJ disruption in response to changes in the dynamics of BCs cultured with entacapone (ENT). Three hours after adding ENT, the ZO‐1‐negative BC surface area ratio became significantly higher (4.1‐fold) than those of ZO‐1‐positive BCs. Based on these data, we calculated slopes of surface area changes, m, of each ZO‐1‐positive and ZO‐1‐negative BC. BCs with m ≤ 15 that fell within the 95% confidence interval of ZO‐1‐positive BCs were defined as ZO‐1‐positive. To validate this method, we compared the frequency of ZO‐1‐positive BCs, F (Z), with that of BCs with m ≤ 15, F (T), in culture using drugs that regulate TJ, or induce intrahepatic cholestasis. F (T) values were correlated with F (Z) under all culture conditions (R (2) = .99). Our results indicate that the magnitude of BC surface area changes is a factor affecting TJ disruption, suggesting that maintaining TJ integrity by slowing BC dilation inhibits cell death. |
format | Online Article Text |
id | pubmed-9137115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91371152022-06-04 Quantitative understanding of HepaRG cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics Sonoi, Rie Hagihara, Yoshihisa Pharmacol Res Perspect Original Articles An understanding of the quantitative relationship between bile canaliculus (BC) dynamics and the disruption of tight junctions (TJs) during drug‐induced intrahepatic cholestasis may lead to new strategies aimed at drug development and toxicity testing. To investigate the relationship between BC dynamics and TJ disruption, we retrospectively analyzed the extent of TJ disruption in response to changes in the dynamics of BCs cultured with entacapone (ENT). Three hours after adding ENT, the ZO‐1‐negative BC surface area ratio became significantly higher (4.1‐fold) than those of ZO‐1‐positive BCs. Based on these data, we calculated slopes of surface area changes, m, of each ZO‐1‐positive and ZO‐1‐negative BC. BCs with m ≤ 15 that fell within the 95% confidence interval of ZO‐1‐positive BCs were defined as ZO‐1‐positive. To validate this method, we compared the frequency of ZO‐1‐positive BCs, F (Z), with that of BCs with m ≤ 15, F (T), in culture using drugs that regulate TJ, or induce intrahepatic cholestasis. F (T) values were correlated with F (Z) under all culture conditions (R (2) = .99). Our results indicate that the magnitude of BC surface area changes is a factor affecting TJ disruption, suggesting that maintaining TJ integrity by slowing BC dilation inhibits cell death. John Wiley and Sons Inc. 2022-05-27 /pmc/articles/PMC9137115/ /pubmed/35621230 http://dx.doi.org/10.1002/prp2.960 Text en © 2022 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Sonoi, Rie Hagihara, Yoshihisa Quantitative understanding of HepaRG cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics |
title | Quantitative understanding of HepaRG cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics |
title_full | Quantitative understanding of HepaRG cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics |
title_fullStr | Quantitative understanding of HepaRG cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics |
title_full_unstemmed | Quantitative understanding of HepaRG cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics |
title_short | Quantitative understanding of HepaRG cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics |
title_sort | quantitative understanding of heparg cells during drug‐induced intrahepatic cholestasis through changes in bile canaliculi dynamics |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137115/ https://www.ncbi.nlm.nih.gov/pubmed/35621230 http://dx.doi.org/10.1002/prp2.960 |
work_keys_str_mv | AT sonoirie quantitativeunderstandingofhepargcellsduringdruginducedintrahepaticcholestasisthroughchangesinbilecanaliculidynamics AT hagiharayoshihisa quantitativeunderstandingofhepargcellsduringdruginducedintrahepaticcholestasisthroughchangesinbilecanaliculidynamics |